Objective:To study the efficacy and safety of Levetiracetam(Lev) monotherapy for different types of infantile epilepsy. Methods:Self controlled follow-up study was conducted for 56 patients with different types of infantile epilepsy using Lev oral monotherapy. Dose of Lev was initially 10 mg/(kg·d)(being administered two times a day),increased by 5-10 mg/(kg·d) every 3-7 d,maintained at 20-40 mg/(kg·d) and finally was increased to 35 mg/kg within 1-2 week. Efficacy and adverse reaction were observed after the treatment. Results:Complete seizure control was found in 29 cases,accounting for 51.78%;effective in 15 cases,accounting for 26.78%;invalid in 12 cases,accounting for 21.44%. Adverse reactions were mainly anorexia,lethargy,emotional rage and behavioral abnormality. Conclusions:Lev monotherapy is effective and safe in the treatment of different types of infantile epilepsy,especially for complex partial seizures and myoclonic seizures. With few adverse reactions,it is a good antiepileptic drug for epilepsy in infants and worth popularizing.